Time-series RNA-Seq upon actinomycin D (ActD) treatment

XG Xinlei Gao
YY Yang Yi
JL Jie Lv
YL Yanqiang Li
KA Kulandaisamy Arulsamy
SB Sahana Suresh Babu
IB Ivone Bruno
LZ Lili Zhang
QC Qi Cao
KC Kaifu Chen
request Request a Protocol
ask Ask a question
Favorite

PrEC and C4-2 cells were treated with transcription inhibitor actinomycin D (ActD, Sigma) at a concentration of 5 μg/ml for 0, 15 min, 1 h and 2 h. RNA samples were then isolated using RNeasy Plus Mini Kit (Qiagen) and sent to BGI for library preparation and follow-up sequencing. Human primary total T cells were isolated from the blood sample of three donors from Gulf Coast Regional Blood Center using Ficoll density gradient method. The cells were collected and washed with PBS + 0.5% FBS and taken into culture. After isolation, the cells were activated with anti-CD3/CD28 microbeads (Thermo Fisher) for 24 h. For transcription inhibition, the cultured cells were treated with ActD (10 μg/ml), for four time points, 0 h (immediately after ActD treatment), 15 min, 1 h and 2 h. After treatment, RNA was isolated by RNeasy kit (Qiagen). The total RNA-seq library construction was performed by RNA core.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A